VANCOUVER, Jan. 13, 2015 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced it will visit the Nasdaq MarketSite in Times Square in celebration of its Nasdaq listing. Neovasc is focused on revolutionizing how advanced heart disease is treated. In honor of the occasion, Alexei Marko, CEO & President and Chris Clark, Chief Financial Officer will ring the Closing Bell.
Nasdaq MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
Tuesday, January 13, 2015 – 3:45 p.m. to 4:00 p.m. ET
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.
Statements in this press release that are not based on historical or current fact are considered "forward-looking statements" in the context of applicable securities laws. No assurances can be given as to the accuracy of these statements and readers are cautioned not to place undue reliance on such forward-looking statements.
SOURCE Neovasc Inc.